# REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

> **NCT03916458** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 62 (actual)

## Conditions studied

- Carcinoma, Renal Cell

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03916458
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-17
- **Primary completion:** 2020-11-03
- **Final completion:** 2020-11-03
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2021-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03916458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03916458, "REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03916458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*